Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Molecular defects underlying the Kell null phenotype.

S Lee1, D C Russo, A P Reiner

  • 1Lindsley F. Kimball Research Institute of the New York Blood Center, New York, New York 10021, USA.

The Journal of Biological Chemistry
|May 26, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genome-wide meta-analysis of variant-by-diuretic interactions as modulators of lipid traits in persons of European and African ancestry.

The pharmacogenomics journal·2019
Same author

Associations of activated coagulation factor VII and factor VIIa-antithrombin levels with genome-wide polymorphisms and cardiovascular disease risk.

Journal of thrombosis and haemostasis : JTH·2017
Same author

Pharmacogenomics study of thiazide diuretics and QT interval in multi-ethnic populations: the cohorts for heart and aging research in genomic epidemiology.

The pharmacogenomics journal·2017
Same author

Large-scale pharmacogenomic study of sulfonylureas and the QT, JT and QRS intervals: CHARGE Pharmacogenomics Working Group.

The pharmacogenomics journal·2016
Same author

Coagulation factor XII genetic variation, ex vivo thrombin generation, and stroke risk in the elderly: results from the Cardiovascular Health Study.

Journal of thrombosis and haemostasis : JTH·2015
Same author

Rare, low frequency and common coding variants in CHRNA5 and their contribution to nicotine dependence in European and African Americans.

Molecular psychiatry·2015
Same journal

Isotope-Edited ESEEM: A New Method for Probing Copper Binding Sites in Neurodegenerative Proteins.

The Journal of biological chemistry·2026
Same journal

Introduction to the Thematic Review Series on Intracellular Protein Degradation. The ubiquitous biology of intracellular protein degradation: a tribute to Alfred L. ("Fred") Goldberg.

The Journal of biological chemistry·2026
Same journal

Correction: Aromatic residue-rich amino-terminal segments of temporin L self-assemble into collagen-mimetic peptides with cell-adhesion properties.

The Journal of biological chemistry·2026
Same journal

YhbO is a DJ-1 family glyoxalase and α-oxoaldehyde hydratase that confers resistance to reactive carbonyl stress (112).

The Journal of biological chemistry·2026
Same journal

ARMH3 acts as a central scaffold at the Golgi/TGN through interactions with Arl5, GBF1, and PI4KB.

The Journal of biological chemistry·2026
Same journal

PAX8 controls proximal tubule epithelial identity and stress response through epigenetic modification of distal regulatory elements.

The Journal of biological chemistry·2026
See all related articles

Multiple genetic defects cause the rare Kell null (Ko) phenotype, characterized by absent Kell antigens. These mutations affect Kell and XK protein expression and cell surface transport.

Area of Science:

  • Hematology
  • Genetics
  • Molecular Biology

Background:

  • The Kell blood group system relies on Kell and XK proteins, essential for red blood cell membrane integrity.
  • The rare Kell null (Ko) phenotype involves the absence of Kell antigens and reduced XK protein on red blood cells.

Observation:

  • This study investigated the molecular basis of the Ko phenotype in eight unrelated individuals.
  • Genetic analysis included sequencing KEL gene coding and splice regions, mRNA analysis, and mutant protein expression studies.

Findings:

  • Six individuals were homozygous for mutations, including premature stop codons and splice site mutations.
  • Two individuals were heterozygous for two distinct mutations, affecting splicing and protein trafficking.
  • Specific mutations (S363N, S676N) resulted in protein mislocalization, preventing cell surface transport.

Related Experiment Videos

Implications:

  • Identifies diverse molecular defects leading to the Kell null phenotype.
  • Highlights the importance of protein trafficking for Kell system expression.
  • Provides insights into the genetic underpinnings of blood group antigen variations.